First‐line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

This phase II, open‐label, single‐arm study investigated sunitinib + FOLFIRI in Japanese patients with treatment‐naïve unresectable/metastatic colorectal cancer. Patients received i.v. FOLFIRI (levo‐leucovorin 200 mg/m(2) + irinotecan 180 mg/m(2), followed by 5‐fluorouracil 400 mg/m(2) bolus then 24...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Autores principales: Tsuji, Yasushi, Satoh, Taroh, Tsuji, Akihito, Muro, Kei, Yoshida, Motoki, Nishina, Tomohiro, Nagase, Michitaka, Komatsu, Yoshito, Kato, Takeshi, Miyata, Yoshinori, Mizutani, Naoko, Hashigaki, Satoshi, Lechuga, Maria Jose, Denda, Tadamichi
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2012
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659192/
https://ncbi.nlm.nih.gov/pubmed/22537162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02320.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares